Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 25;8(5):2416-24.
doi: 10.19082/2416. eCollection 2016 May.

A Review of the Clinical Implications of Breast Cancer Biology

Affiliations
Review

A Review of the Clinical Implications of Breast Cancer Biology

Yekta Parsa et al. Electron Physician. .

Abstract

Background: Histologically similar tumors may have different prognoses and responses to treatment. These differences are due to molecular differences. Hence, in this review, the biological interaction of breast cancer in several different areas is discussed. In addition, the performance and clinical application of the most widely-recognized biomarkers, metastasis, and recurrences from a biological perspective and current global advances in these areas are addressed.

Objective: This review provides the performance and clinical application of the most widely-recognized biomarkers, metastasis, and recurrences from the biological perspective and current global advances in these areas.

Methods: PubMed, Scopus, and Google Scholar were searched comprehensively with combinations of the following keywords: "breast cancer," "biological markers," and "clinical." The definition of breast cancer, diagnostic methods, biological markers, and available treatment approaches were extracted from the literature.

Results: Estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor-2 (HER-2), and Ki-67 are the most well-known biological markers that have important roles in prognosis and response to therapeutic methods. Some studies showed the response of ER-positive and PR-negative tumors to anti-estrogenic treatment to be lower than ER-positive and PR-positive tumors. Patients with high expression of HER-2 and Ki-67 had a poor prognosis. In addition, recent investigations indicated the roles of new biomarkers, such as VEGF, IGF, P53 and P21, which are associated with many factors, such as age, race, and histological features.

Conclusion: The objective of scientists, from establishing a relationship between cancer biology infrastructures with clinical manifestations, is to find new ways of prevention and progression inhibition and then possible introduction of less dangerous and better treatments to resolve this dilemma of human society.

Keywords: Estrogen receptor; biological markers; breast cancer; human epidermal growth factor receptor-2; progesterone receptor.

PubMed Disclaimer

References

    1. Howell A, Sims AH, Ong KR, Harvie MN, Evans DGR, Clarke RB. Mechanisms of Disease: prediction and prevention of breast cancer-cellular and molecular interactions. Nat Clin Pract Oncol. 2005;2(12):635–46. doi: 10.1038/ncponc0361. - DOI - PubMed
    1. Varangot M, Barrios E, Sóñora C, Aizen B, Pressa C, Estrugo R, et al. Clinical evaluation of a panel of mRNA markers in the detection of disseminated tumor cells in patients with operable breast cancer. Oncol rep. 2005;14(2):537–45. doi: 10.3892/or.14.2.537. - DOI - PubMed
    1. Gerrero MR, Weber BL. Recent advances in breast cancer biology. Curr opin oncol. 2001;13(6):415–9. doi: 10.1097/00001622-200111000-00001. - DOI - PubMed
    1. Steel C, Smyth E. Molecular pathology of breast cancer and its impact on clinical practice. Schweiz Med Wochenschr. 1999;129(46):1749–57. - PubMed
    1. Chassevent A, Jourdan M-L, Romain S, Descotes F, Colonna M, Martin P-M, et al. S-Phase Fraction and DNA Ploidy in 633 T1T2 breast cancers a standardized flow cytometric study. Clin Cancer Res. 2001;7(4):909–17. - PubMed

LinkOut - more resources